Short-term efficacy and safety of rituximab therapy in refractory systemic lupus erythematosus: results from the British Isles Lupus Assessment Group Biologics Register.

about

Successful use of ofatumumab in two cases of early-onset juvenile SLE with thrombocytopenia caused by a mutation in protein kinase C δ

P2860

Q58695163-616545C1-14DE-4F0A-BEA8-1F127A2D18A0

P2860

Short-term efficacy and safety of rituximab therapy in refractory systemic lupus erythematosus: results from the British Isles Lupus Assessment Group Biologics Register.

Item

http://www.wikidata.org/entity/Q47687376

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh

2018年學術文章

@zh-hant

name

Short-term efficacy and safety ...... ment Group Biologics Register.

@en

Short-term efficacy and safety ...... ment Group Biologics Register.

@nl

type

Item

label

Short-term efficacy and safety ...... ment Group Biologics Register.

@en

Short-term efficacy and safety ...... ment Group Biologics Register.

@nl

prefLabel

Short-term efficacy and safety ...... ment Group Biologics Register.

@en

Short-term efficacy and safety ...... ment Group Biologics Register.

@nl

P1154

2-s2.0-85043333925

http://www.w3.org/2001/XMLSchema#string

P1433

Rheumatology

P1476

Short-term efficacy and safety ...... ment Group Biologics Register.

@en

P2093

Asad Zoma

http://www.w3.org/2001/XMLSchema#string

Benjamin Rhodes

http://www.w3.org/2001/XMLSchema#string

Bridget Griffiths

http://www.w3.org/2001/XMLSchema#string

British Isles Lupus Assessment Group Biologics Register

http://www.w3.org/2001/XMLSchema#string

Chee-Seng Yee

http://www.w3.org/2001/XMLSchema#string

Christopher J Edwards

http://www.w3.org/2001/XMLSchema#string

David Jayne

http://www.w3.org/2001/XMLSchema#string

David P D'Cruz

http://www.w3.org/2001/XMLSchema#string

Edward M Vital

http://www.w3.org/2001/XMLSchema#string

Emily Sutton

http://www.w3.org/2001/XMLSchema#string

P2860

A phase III, randomized, placebo-controlled study of belimumab, a monoclonal antibody that inhibits B lymphocyte stimulator, in patients with systemic lupus erythematosus

Efficacy and safety of belimumab in patients with active systemic lupus erythematosus: a randomised, placebo-controlled, phase 3 trial

Factors associated with damage accrual in patients with systemic lupus erythematosus: results from the Systemic Lupus International Collaborating Clinics (SLICC) Inception Cohort

Efficacy and safety of epratuzumab in patients with moderate/severe active systemic lupus erythematosus: results from EMBLEM, a phase IIb, randomised, double-blind, placebo-controlled, multicentre study

Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus

Efficacy and safety of rituximab in the treatment of non-renal systemic lupus erythematosus: a systematic review.

Tocilizumab in systemic lupus erythematosus: data on safety, preliminary efficacy, and impact on circulating plasma cells from an open-label phase I dosage-escalation study.

High prevalence of systemic disease and mortality in Asian subjects with systemic lupus erythematosus

Numerical scoring for the BILAG-2004 index

Efficacy of rituximab in 164 patients with biopsy-proven lupus nephritis: pooled data from European cohorts.

P304

470-479

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/RHEUMATOLOGY/KEX395

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

P5530

30018564

http://www.w3.org/2001/XMLSchema#string

P577

2018-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1092539110

http://www.w3.org/2001/XMLSchema#string

P6409

185507076

http://www.w3.org/2001/XMLSchema#string

P698

29216396

http://www.w3.org/2001/XMLSchema#string

P932

5850287

http://www.w3.org/2001/XMLSchema#string

P953

136215